Live biotherapeutics: Emerging trends and future directions in microbial therapy
Authors:
- 16 December 2025
- book chapter
- Published by Elsevier
- Vol. 220, 1-35
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research, India
This publication has 73 references indexed in Scilit:
- Repurposing endogenous type II CRISPR‐Cas9 system for genome editing in Streptococcus thermophilusBiotechnology and Bioengineering, 2023
- VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile InfectionJAMA, 2023
- Gut microbiome dysbiosis in inflammatory bowel disease2022
- Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteersCell Host & Microbe, 2022
- Probiotic supplementation demonstrates therapeutic potential in treating gut dysbiosis and improving neurocognitive function in age-related dementiaEuropean Journal of Nutrition, 2022
- Bifidobacterium animalis subsp. lactis lkm512 Attenuates Obesity‐Associated Inflammation and Insulin Resistance Through the Modification of Gut Microbiota in High‐Fat Diet‐Induced Obese MiceMolecular Nutrition & Food Research, 2021
- Homeostasis and dysbiosis of the gut microbiome in health and diseaseJournal of Biosciences, 2019
- Efficient engineered probiotics using synthetic biology approaches: A reviewBiotechnology and Applied Biochemistry, 2019
- Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMTCell, 2018
- Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data AnalysisInfectious Diseases and Therapy, 2016